Dr. Jean K. Mathew, MD

Dr. Mathew practices at Northwest Renal Clinic, Inc. in Portland, Oregon.

Dr. Mathew's NPI, 1497730808, was assigned on December 8, 2005. Dr. Mathew holds Oregon license MD184703.

Dr. Mathew's primary practice is Northwest Renal Clinic, Inc., at 9155 SW Barnes Rd, Portland, OR 97225 in Washington County. The practice phone is (503) 229-7976.

Dr. Mathew's primary practice is Northwest Renal Clinic, Inc. in Portland, Oregon. Dr. Mathew is also affiliated with OHSU Hospital. The medical group on file is Northwest Renal Clinic. Dmand AI also links Dr. Mathew to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathew practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mathew's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Mathew's licenses on file in 2 states: Oregon and Hawaii.

CMS data shows 1,671 Medicare services from Dr. Mathew across 17 procedure codes in 2024, for 357 Medicare patients. Medicare paid $113,569 for them.

CMS counts 357 Medicare patients who saw Dr. Mathew in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 4.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mathew's median patient age at 70, with 51% women.

In 2024, Dr. Mathew wrote 1,164 Medicare Part D claims for 293 patients. 84% of them were for generic drugs. CMS names the drug for 996 of them, across 23 drugs with 11 or more claims each, at $195,345 in total drug cost. In 2023, CMS named 813 claims across 22 drugs.

Dr. Mathew accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mathew as offering telehealth.

CMS Open Payments shows 20 general payments to Dr. Mathew from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $246.